NasdaqHealth CareHealth Care EquipmentS&P SmallCap 600
$303.47
+3.65 (+1.22%)
Close of Nov 06, 2026 · end-of-day data
UFPT 8-K filings, explained
Every material Form 8-K UFP Technologies has filed with the SEC since February 25, 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
For the quarter ended September 30, 2026, UFP Technologies reported net sales of $172.4 million, up 11.6% from $154.6 million, and net income of $20.6 million, up 25.8%. Diluted GAAP EPS was $2.64 versus $2.11 a year earlier, and gross margin rose to 29.4% from 27.7%. Management said scheduled program transfers to the Dominican Republic and margin improvement remain behind plan, and the company is working to expand its credit facility.
Q3 net sales were $172.4 million, up 11.6% from $154.6 million; organic sales growth was 11.1%.
Q3 GAAP diluted EPS was $2.64 versus $2.11; adjusted diluted EPS was $2.88 versus $2.39.
Q3 gross margin was 29.4% versus 27.7%; SG&A rose 21.4% to $23.2 million.
Nine-month net sales were $500.6 million, up 10.3%; the company is working to expand its credit facility.
UFP Technologies reported record second-quarter 2026 results, with net sales up 15.1% to $174.0 million and net income up 21.4% to $20.9 million from a year earlier. The company also said its Dominican Republic investments are creating near-term mix and margin pressure in its U.S. operations, which shareholders may weigh against the higher sales and profit.
Q2 2026 net income was $20.9 million, up from $17.2 million in Q2 2025; GAAP diluted EPS was $2.68 versus $2.21
Adjusted diluted EPS was $2.92 versus $2.50; organic sales growth was 12.4% for the quarter
SG&A rose 21.8% to $22.8 million, and gross margin increased to 29.3% from 28.8%
The company will hold a conference call on Tuesday, August 4, 2026, at 8:30 AM Eastern
UFP Technologies appointed Ryan Stafford as General Counsel, Senior Vice President of Human Resources, and Secretary, effective June 4, 2026, succeeding Christopher Litterio, who is retiring after a transition period. The company also appointed Mitchell C. Rock as Chief Executive Officer and added him to the Board, which was expanded from seven to eight members.
Ryan Stafford, age 58, previously served as EVP, Chief Legal Officer and head of M&A at Littelfuse, Inc.
Stafford's base salary is $400,000, with a target bonus of 50% of base salary, and a 2026 equity award with a grant-date value of $650,000.
Mitchell C. Rock was appointed CEO effective June 4, 2026, and received stock unit awards worth $650,000 at the June 4 meeting.
Ronald J. Lataille, Senior Vice President, Treasurer and CFO, received a grant of 4,454 stock unit awards, worth $1 million.
UFP Technologies disclosed that Christopher P. Litterio, its General Counsel, Secretary, and Senior Vice President of Human Resources, plans to retire after a transition period. The filing does not give a retirement date or name a successor, so shareholders will need later disclosures to learn how the three roles will be covered.
Litterio informed the company of his retirement plans on May 19, 2026.
He holds three roles: General Counsel, Secretary, and Senior Vice President of Human Resources.
The filing gives no specific retirement date and does not name a successor.
The 8-K was dated May 26, 2026 and signed by CFO Ronald J. Lataille.
UFP Technologies reported first-quarter 2026 results for the period ended March 31, 2026, with net sales up 4.1% to $154.2 million and net income up 1.8% to $17.5 million. GAAP diluted EPS was $2.24, up from $2.21, while adjusted EPS was $2.48 compared with $2.47 a year earlier. Organic sales were essentially flat, and management said EPS growth lagged revenue growth due to softer results at its AJR operation and start-up costs for four large programs.
Net sales rose 4.1% to $154.2 million, from $148.1 million; organic sales were essentially flat, with 0.4% organic growth per the filing's reconciliation.
Net income was $17.5 million versus $17.2 million; GAAP diluted EPS was $2.24 versus $2.21, and adjusted EPS was $2.48 versus $2.47.
Non-medical sales fell 15.0% to $10.8 million, while medical sales rose 5.9% to $143.4 million.
Management expects four large programs to be significant contributors in the second half of 2026, and a conference call is scheduled for May 5, 2026, at 8:30 AM Eastern time.
UFP Technologies and customer Intuitive Surgical signed Amendment No. 27 to their manufacturing supply agreement on February 19, 2026, effective January 1, 2026. The amendment extends the agreement by two years through December 31, 2029, raises annual minimum volumes for the largest program in 2028 and 2029, and adds a new program, which points to a longer and larger commitment from a key medical customer.
Amendment No. 27 signed February 19, 2026 and effective January 1, 2026
Agreement term extended two years, through December 31, 2029
Annual minimum volumes for the largest program increased for 2028 and 2029; an additional program added
Volume-based pricing and cost-sharing provisions added; dollar amounts not disclosed in the filing
UFP Technologies disclosed a material cybersecurity incident after detecting suspicious activity in its IT systems on or about February 14, 2026. The company says the attacker has been removed, access has been restored in all material respects, and operations have continued in all material respects, though some data appears to have been stolen or destroyed and the investigation into personal information is ongoing. The company expects a significant portion of direct response costs to be reimbursed by insurance and does not believe the incident is reasonably likely to materially affect its financial condition or results of operations.
Suspicious activity detected on or about February 14, 2026; affected billing and label making for customer deliveries
Company says the third party has been removed and access restored in all material respects
Certain company data appears stolen or destroyed; investigation into personal information and required notifications is ongoing
Company expects a significant portion of direct response costs to be covered by insurance recoveries
UFP Technologies reported fiscal 2025 net sales of $602.8 million, up 19.5%, and GAAP diluted EPS of $8.75, up from $7.58. Fourth-quarter results were weaker: sales rose 3.4% to $148.9 million, but operating income fell 3.4% and adjusted EPS slipped to $2.44 from $2.46. Shareholders should note that the company attributed about $6.3 million of labor-related inefficiencies at its Illinois facility to 2025 results.
Full-year 2025 net income was $68.3 million, up 15.8%, and adjusted EPS was $9.76 versus $8.68 in 2024.
Fourth-quarter 2025 sales were $148.9 million, up 3.4%, with organic sales essentially flat; gross margin fell to 28.2% from 29.2%.
Full-year organic growth was approximately 1.5%, while acquisitions contributed $90.7 million of 2025 net sales.
Long-term debt fell to $123.0 million at December 31, 2025, from $176.9 million a year earlier.
UFP Technologies said its president, Mitchell C. Rock, will become Chief Executive Officer on June 4, 2026, when Mr. Bailly retires from that role and becomes Executive Chairman through his retirement in 2027. The filing sets Mr. Rock's base salary at $700,000, a target long-term incentive of up to $1,750,000 in restricted stock units, and a one-time $650,000 restricted stock unit grant, with severance terms that include a larger payout if a change of control occurs.
Mitchell C. Rock becomes CEO effective June 4, 2026; Mr. Bailly retires as CEO on that date and remains Executive Chairman through 2027.
Mr. Rock's base salary is $700,000 per year after the appointment date, with an annual bonus target of up to 100% of base salary.
Mr. Rock's severance without a change of control is 18 months of base salary; a change of control termination pays two times salary plus full target bonus.
Effective January 1, 2026, the board's committee raised base salaries for the named executive officers, including $505,000 for CFO Ronald J. Lataille.
UFP Technologies said CEO R. Jeffrey Bailly will retire at the annual stockholders meeting scheduled for June 4, 2026, and that President Mitchell Rock will become CEO and join the Board at that time. Bailly will serve as Executive Chairman for the following year. The filing says his retirement was not due to any disagreement with the company, including on accounting principles and practices, and the change sets a planned succession for shareholders.
Bailly retires as CEO effective at the annual meeting scheduled for June 4, 2026, and will remain on the Board as Executive Chairman.
Mitchell Rock, 58, joined the company in 1991 and has been President since February 2024; his CEO appointment is subject to signing an employment offer letter.
The company's press release says revenue grew about 20-fold and profitability and market capitalization grew more than 150-fold during Bailly's 31 years as CEO.
UFP Technologies reported third-quarter 2025 sales of $154.6 million, up 6.5%, while net income of $16.4 million and diluted EPS of $2.11 were flat with a year earlier. Higher costs, including about $3 million in incremental labor expense at its Illinois AJR facility, pushed gross margin down to 27.7% and operating income down 5.6%. Nine-month sales rose 26.0% to $453.9 million and diluted EPS rose to $6.52 from $5.49, though the filing gives no forward guidance.
Q3 2025 sales were $154.6 million, up 6.5% from $145.2 million; organic sales were essentially flat.
Q3 diluted EPS was $2.11, the same as Q3 2024; adjusted EPS was $2.39 versus $2.49.
Gross margin fell to 27.7% from 28.6%, and about $3 million in incremental labor cost was incurred at the AJR facility.
Nine-month net income was $50.7 million, or $6.52 per diluted share, versus $42.6 million, or $5.49, a year earlier.
UFP Technologies reported second-quarter 2025 net income of $17.2 million, or $2.21 per diluted share, up from $13.6 million, or $1.75, a year earlier. Sales rose 37.2% to $151.2 million, helped by two acquisitions and 4.9% organic growth, while gross margin fell to 28.8% from 30.0%.
Q2 sales increased 37.2% to $151.2 million from $110.2 million; organic sales growth was 4.9%.
Q2 net income was $17.2 million, or $2.21 per diluted share, versus $1.75 a year earlier; adjusted EPS rose 27% to $2.50.
Gross margin fell to 28.8% from 30.0%, including about $1.2 million in incremental labor costs at its AJR facility, which the company expects to be the low point in Q3.
UFP Technologies reported first-quarter 2025 results, with net sales of $148.1 million, up 41.1% from $105.0 million a year earlier, and net income of $17.2 million, or $2.21 per diluted share, versus $1.64 in the first quarter of 2024. Organic sales growth was 2.3%, and gross margin edged down to 28.5% from 28.6%. The press release does not include financial guidance.
Net sales rose 41.1% to $148.1 million for the quarter ended March 31, 2025, from $105.0 million; medical market sales rose 50.4% to $135.4 million.
Net income rose 35.4% to $17.2 million, and diluted EPS was $2.21 versus $1.64 a year earlier.
Organic sales growth was 2.3%, and gross margin was 28.5% versus 28.6% in the first quarter of 2024.
Long-term debt, excluding current installments, was $170.3 million at March 31, 2025, down from $176.9 million at December 31, 2024.
On March 31 and March 26, 2025, subsidiary AJR Enterprises signed two supply agreements with Sage Products, LLC (Stryker), the company's second-largest customer. Stryker agreed to buy 100% of its requirements for certain products from AJR on an exclusive basis, and the company agreed to buy the equipment needed to make them and to move that manufacturing to the Dominican Republic over two years. The filing does not disclose revenue or dollar amounts for the agreements.
March 31, 2025 agreement: exclusive purchase commitment for a 42-month period starting January 1, 2026.
March 26, 2025 amended agreement: exclusive purchase commitment for about 63 months, effective April 24, 2024.
Company will move manufacturing to the Dominican Republic over the next two years; Stryker is eligible for price reductions as products transfer.
Stryker's purchase requirement ends if certain events occur, such as the company failing to meet regulatory or quality requirements.
UFP Technologies disclosed that Steve Cardin, its Vice President and Chief Operating Officer of the MedTech business, resigned on March 15, 2025. His last day with the company will be March 28, 2025. The filing does not name a successor or describe the reasons for the departure.
Steve Cardin, Vice President and Chief Operating Officer of the MedTech business, tendered his resignation on March 15, 2025
Last day with the company will be March 28, 2025
The filing does not name a replacement or give a reason for the departure
UFP Technologies reported fourth-quarter and full-year 2024 results on February 25, 2025. Full-year net sales rose 26.1% to $504.4 million and GAAP diluted EPS was $7.58, compared with $5.83 in 2023, while fourth-quarter sales grew 41.9% to $144.1 million. Long-term debt, less current portion, was $176.9 million at December 31, 2024, up from $28.0 million a year earlier.
Full-year 2024 net income was $59.0 million, up 31.3% from $44.9 million; GAAP diluted EPS was $7.58 versus $5.83.
Fourth-quarter 2024 net sales were $144.1 million, up 41.9%; GAAP diluted EPS was $2.10 versus $1.51.
Full-year MedTech sales rose 30.2% to $450.8 million; gross margin was 29.1% versus 28.1%.
Long-term debt, less current portion, was $176.9 million at December 31, 2024, versus $28.0 million at December 31, 2023.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every UFP Technologies filing is on SEC EDGAR ↗. 8-K briefs of other companies →